iBio (IBIO) Operating Margin (QoQ) (2011 - 2025)

iBio (IBIO) Operating Margin (QoQ) (2011 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 iBio 172.22 Mn 172.22 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -335,200.00
Sep 30, 2021 -429,783.00
Jun 30, 2021 -98,083.00
Mar 31, 2021 12,864.00
Dec 31, 2020 61,857.00
Sep 30, 2020 -142,726.00
Jun 30, 2020 397,182.00
Mar 31, 2020 -322,856.00
Dec 31, 2019 256,467.00
Sep 30, 2019 -305,963.00
Jun 30, 2019 20,556.00
Mar 31, 2019 -9,863.00
Dec 31, 2018 816,103.00
Sep 30, 2018 -444,151.00
Jun 30, 2018 14,194.00
Mar 31, 2018 -223,834.00
Dec 31, 2017 51,505.00
Sep 30, 2017 -12,975.00
Jun 30, 2017 801,267.00
Mar 31, 2017 -620,450.00